Ewing's sarcoma of the rectum: Can we afford not to use molecular pathology? [19]

Journal of Clinical Oncology

Volumn 23, Issue 30, 2005, Pages 7761-7762

  Pierga, Jean Yves ^a   Reis Filho, Jorge S ^b  

^a INSTITUT CURIE   (France)

^b Breakthrough Toby Robins Breast Cancer Research Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD99 ANTIGEN; CHROMOGRANIN; CYTOKERATIN; DESMIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100; SMOOTH MUSCLE ACTIN; VIMENTIN;

CANCER DIAGNOSIS; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; EWING SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MICROSCOPY; PRIORITY JOURNAL; RECTUM TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; NOTE;

HUMANS; RECTAL NEOPLASMS; SARCOMA, EWING'S;

EID: 32944473613     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.5735     Document Type: Letter

References (7)

1. Vardy J, Joshua AM, Clarke SJ, et al: Small blue cell tumors of the rectum, CASE 1: Ewing's Sarcoma of the Rectum. J Clin Oncol 23:910-912, 2005
2. Ozdemirli M, Fanburg-Smith JC, Hartmann DP, et al: Differentiating lymphoblastic lymphoma and Ewing's sarcoma: Lymphocyte markers and gene rearrangement. Mod Pathol 14:1175-1182, 2001
3. Pelosi G, Fraggetta F, Sonzogni A, et al: CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumors. Virchows Arch 437:270-274, 2000
4. Rosai J: Rosai and Ackerman's Surgical Pathology (ed 9). New York, NY, Mosby, 2004
5. Kohno S, Ohshima K, Yoneda S, et al: Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology 43:135-143, 2003
6. Burchill SA: Ewing's sarcoma: Diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J Clin Pathol 56:96-102, 2003
7. Drut R, Drut M, Muller C, et al: Rectal primitive neuroectodermal tumor. Pediatr Pathol Mol Med 22:391-398, 2003